Better Control For Controlled Substances

Addressing a Critical Unmet Need in the Opioid Crisis

Verinetics is committed to providing solutions that reduce stigma and preserve personal dignity and independence for individuals on their recovery journey and to supporting the overall healthcare ecosystem in our quest to prevent future challenges for our communities. For us, it is personal.

$35B

Untreated OUD leads to an estimated $35 billion in increased healthcare spending annually.

DispenSecur™

DispenSecur™ is a specialized lockbox to support OTP providers offering take-home doses of methadone for more individuals with OUD.

Two Component System

Secure Bottle Dispensing Unit for Patients

  • Built inside a familiar lockbox with a simple, user-friendly interface

  • Provides both physical and electronic security, presenting only one dose of medication at the intended time

  • Compatible with standard OTP procedures for liquid methadone dispensing

Secure Cloud-Based Interface for Providers

  • Serves as the interface to configure the dispensing unit for controlled medication access on a schedule

  • Presents a remote, real-time view to a dispensing activity log and facilitates inventory tracking

  • GPS location monitoring for the unit

Watch a demo of the patient experience using DispenSecur™ for scheduled access to methadone at home.

Facilitating Broader Access

DispenSecur™ enables providers to dispense take-home methadone for up to two weeks supporting:

  • Reduced clinic visits

  • Secure, timely medication delivery at home

  • Expanded accessibly for underserved populations and geographical areas.

DispenSecur™ is intended to facilitate clinical practices consistent with the new rules from SAMHSA to ensure accessible, destigmatized care for those with OUD.

Reference: https://www.samhsa.gov/medications-substance-use-disorders/statutes-regulations -guidelines /42-cfr-part-8

Building Trust Together

Verinetics designed the DispenSecur™ solution to allow providers to monitor use of medications from the time individuals leave the clinic to the moment they access each of their daily doses of methadone.

Monitoring is strictly based on data analytics and not observing dose administration, allowing preservation of individual independence.

Verinetics is Enabling New Roads to Substance Use Disorder Recovery and Prevention

DispenSecur™ is a Class I Medical Device listed with the Food and Drug Administration for distribution in the United States and is intended for medical purposes to provide alerts and controlled patient access to medication based on dosing schedules predetermined by a healthcare provider. The device may be used with either liquid or solid dosage forms of one medication type. The device is not intended to manage multiple medications.